Abstract
Spinal muscular atrophy (SMA) is primarily a neurodegenerative disease caused by the homozygous deletion of the survival motor neuron 1 (SMN1) gene, thereby reducing SMN protein expression. Mesenchymal stem cells (MSCs) have been implicated in the treatment of SMA. In the present study, we overexpressed exogenous SMN1 at the ribosomal DNA (rDNA) locus of induced pluripotent stem cells (iPSCs) generated from a SMA patient using an rDNA-targeting vector. The gene-targeted patient iPSCs differentiated into MSCs (SMN1-MSCs). A 2.1-fold higher expression level of SMN protein was detected in SMN1-MSCs than that detected in MSCs derived from patient iPSCs, and the results of the immunofluorescence analysis showed no difference in the quantity of SMN nuclear structures (gems) between SMN1-MSCs and MSCs derived from normal human iPSCs (h-MSCs). These findings provide a novel strategy for obtaining gene-targeted MSCs for potential clinical applications in autologous cell-based therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdullah RH, Yaseen NY, Salih SM, Al-Juboory AA, Hassan A, Al-Shammari AM (2016) Induction of mice adult bone marrow mesenchymal stem cells into functional motor neuron-like cells. J Chem Neuroanat 77:129–142. https://doi.org/10.1016/j.jchemneu.2016.07.003
Arnold AS, Gueye M, Ronde P, Warter JM, Poindron P, Gies JP (2002) Construction of a plasmid containing human SMN, the SMA determining gene, coupled to EGFP. Plasmid 47:79–87. https://doi.org/10.1006/plas.2002.1564
Bagher Z et al (2016) Differentiation of Wharton’s jelly-derived mesenchymal stem cells into motor neuron-like cells on three-dimensional collagen-grafted nanofibers. Mol Neurobiol 53:2397–2408. https://doi.org/10.1007/s12035-015-9199-x
Boda B et al (2004) Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells. Eur J Hum Genet 12:729–737. https://doi.org/10.1038/sj.ejhg.5201217
Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:14. https://doi.org/10.1186/1471-2121-7-14
Chen Q et al (1998) Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP. Genomics 48:121–127. https://doi.org/10.1006/geno.1997.5141
Choi MR et al (2010) Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Neurosci Lett 472:94–98. https://doi.org/10.1016/j.neulet.2010.01.054
Cui B, Li E, Yang B, Wang B (2014) Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury. Exp Ther Med 7:1233–1236. https://doi.org/10.3892/etm.2014.1608
DiDonato CJ, Parks RJ, Kothary R (2003) Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implications for spinal muscular atrophy therapy. Hum Gene Ther 14:179–188. https://doi.org/10.1089/104303403321070874
Diederichs S, Tuan RS (2014) Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev 23:1594–1610. https://doi.org/10.1089/scd.2013.0477
Dominguez E et al (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20:681–693. https://doi.org/10.1093/hmg/ddq514
Fan Y, Wu DZ, Gong YQ, Xu R, Hu ZB (2002) Metabolic responses induced by thrombin in human umbilical vein endothelial cells. Biochem Biophys Res Commun 293:979–985. https://doi.org/10.1016/S0006-291X(02)00339-X
Finkel RS et al (2016) Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388:3017–3026. https://doi.org/10.1016/S0140-6736(16)31408-8
Heeschen C et al (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615–1622. https://doi.org/10.1161/01.CIR.0000124476.32871.E3
Hoch RV, Soriano P (2003) Roles of PDGF in animal development. Development 130:4769–4784. https://doi.org/10.1242/dev.00721
Hu Y et al (2013) Nonviral gene targeting at rDNA locus of human mesenchymal stem cells. Biomed Res Int 2013:135189. https://doi.org/10.1155/2013/135189
Kilian O, Flesch I, Wenisch S, Taborski B, Jork A, Schnettler R, Jonuleit T (2004) Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 9:337–344
Kolb SJ, Kissel JT (2011) Spinal muscular atrophy: a timely review. Arch Neurol 68:979–984. https://doi.org/10.1001/archneurol.2011.74
Lian Q et al (2010) Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121:1113–1123. https://doi.org/10.1161/CIRCULATIONAHA.109.898312
Liu X et al (2007) Non-viral ex vivo transduction of human hepatocyte cells to express factor VIII using a human ribosomal DNA-targeting vector. J Thromb Haemost 5:347–351. https://doi.org/10.1111/j.1538-7836.2007.02355.x
Liu X et al (2012) Targeting of the human coagulation factor IX gene at rDNA locus of human embryonic stem cells. PLoS ONE 7:e37071. https://doi.org/10.1371/journal.pone.0037071
Lorson CL, Rindt H, Shababi M (2010) Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 19:R111–R118. https://doi.org/10.1093/hmg/ddq147
Pang J et al (2016) Targeting of the human F8 at the multicopy rDNA locus in hemophilia A patient-derived iPSCs using TALENickases. Biochem Biophys Res Commun 472:144–149. https://doi.org/10.1016/j.bbrc.2016.02.083
Paton DM (2017) Nusinersen: antisense oligonucleotide to increase SMN protein production in spinal muscular atrophy. Drugs Today 53:327–337. https://doi.org/10.1358/dot.2017.53.6.2652413
Pearn J (1980) Classification of spinal muscular atrophies. Lancet 1:919–922
Rashnonejad A, Gunduz C, Susluer SY, Onay H, Durmaz B, Bandehpour M, Ozkinay F (2016) In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression. Gene Ther 23:10–17. https://doi.org/10.1038/gt.2015.92
Sakai K, Ohta T, Minoshima S, Kudoh J, Wang Y, de Jong PJ, Shimizu N (1995) Human ribosomal RNA gene cluster: identification of the proximal end containing a novel tandem repeat sequence. Genomics 26:521–526
Stults DM, Killen MW, Pierce HH, Pierce AJ (2008) Genomic architecture and inheritance of human ribosomal RNA gene clusters. Genome Res 18:13–18. https://doi.org/10.1101/gr.6858507
Vercelli A et al (2008) Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31:395–405. https://doi.org/10.1016/j.nbd.2008.05.016
Villanova M, Bach JR (2015) Allogeneic mesenchymal stem cell therapy outcomes for three patients with spinal muscular atrophy type 1. Am J Phys Med Rehabil 94:410–415. https://doi.org/10.1097/PHM.0000000000000309
Wirth B (2000) An update of the mutation spectrum of the survival motor neuron gene(SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15:228–237. 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9
Wu Y et al (2014) TALE nickase mediates high efficient targeted transgene integration at the human multi-copy ribosomal DNA locus. Biochem Biophys Res Commun 446:261–266. https://doi.org/10.1016/j.bbrc.2014.02.099
Yang J et al (2009) A non-viral vector for potential DMD gene therapy study by targeting a minidystrophin-GFP fusion gene into the hrDNA locus. Acta Biochim Biophys Sin 41:1053–1060
Acknowledgements
This work was financially supported by grants from the National Natural Science Foundation of China (81400928, 81271944, and 81272540), the National Key R&D Program of China (2016YFC0905100) and the Fundamental Research Funds for the Central Universities of Central South University (2016zzts168).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Feng, M., Liu, C., Xia, Y. et al. Restoration of SMN expression in mesenchymal stem cells derived from gene-targeted patient-specific iPSCs. J Mol Hist 49, 27–37 (2018). https://doi.org/10.1007/s10735-017-9744-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-017-9744-1